archive image

European Commission - Research - Biosociety

Biosociety and the Knowledge-Based Bio-Economy
Knowledge based bio-economy
EU-funded research
Focus on socio-economics
Focus on bioethics
Science and governance
Success stories
Research projects
Page last update: 25/12/2008

Fifth Framework Programme
Quality of Life Programme - Key Action 2: Control of infectious diseases

European Union-backed research projects focusing on the socio-economic aspects of the life sciences and biotechnologies sectors are presented below. These projects, listed with their title and contract number, were carried out during the Fifth Framework Programme (1998-2002) under Quality of life programme, and relate to the control of infectious diseases.

Development of strategies for control and prevention of antibiotic resistance in European Hospitals - QLK2-CT-2001-00915

Creutzfeldt-Jacob disease: epidemiology, risk factors, diagnostic tests and genetics - QLK2-CT-2001-02248

Human Transmissible Spongiform Encephalopathies: The Neuropathology network - QLK2-CT-2000-00837

New generation genetic markers and techniques for the epidemiology and control of tuberculosis - QLK2-CT-2000-00630

Sea-Lice Resistance to Chemotherapeutants diagnosis, mechanisms, dynamics and control - QLK2-CT-2000-00809

Paediatric European Network For Treatment AIDS - QLK2-CT-2000-00150

Human Pneumocystis carinii infection in immunocompetent hosts: a public health issue in Europe - QLK2-CT-2000-01369

Concerted Action on SeroConversion to AIDS and Death in Europe - QLK2-CT-2000-01431

European Collaborative Study on Pregnant HIV-Infected Women and their children - QLK2-CT-2000-00002

Establishment of novel targets for risk assessment and monitoring of xenogeneic infections in the course of animal to human transplantation - QLK2-CT-1999-40210

Improving Vaccination in Early Life (Neovac) - QLK2-CT-1999-00429

Development of an efficacious vaccine against animal brucellosis that is harmless for humans - QLK2-CT-1999-00014

A cluster for tuberculosis vaccine development - QLK2-CT-1999-01093

Generic coronavirus vaccine vectors for protection of farm animals against mucosal infection - QLK2-CT-1999-00002

A European malaria vaccine development consortium: EUROMALVAC 1 - QLK2-CT-1999-01293

European (EURO) network for development of novel safe vaccines based on new generation Amplicons (AMP) and other Defective HSV-1 derived vectors as foreign antigen delivery systems - QLK2-CT-1999-00055

Mucosal immunisation - Cluster project - QLK2-CT-1999-00228

Development of therapeutic vaccines for chronic infections caused by the hepatitis c virus - QLK2-CT-1999-00588

European network for vaccine evaluation in primates: combined vector immunisations for AIDS vaccine development - QLK2-CT-1999-00871

Bivalent hantavirus vaccine for Europe: Different approaches and evaluation in animal models - QLK2-CT-1999-01119

SIV/HIV vaccines: Detecting efficacy and explaining inefficacy - QLK2-CT-1999-01215

European vaccine effort against HIV/AIDS - QLK2-CT-1999-01321<


Last update: 25 December 2008 | Top